We are live on
!
Find out more
SM
SB Management Portfolio holdings
AUM
$516M
1-Year Est. Return
40.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.2%
1 Year Est. Return
-40.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.5B
AUM Growth
-$2.17B
(-12%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-16.26%
Top 10 Holdings %
Top 10 Hldgs %
95.69%
Holding
32
New
20
Increased
2
Reduced
9
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sana Biotechnology
SANA
|
+$85.5M |
| 2 |
GeneDx Holdings
WGS
|
+$53.3M |
| 3 |
HERAU
FTAC Hera Acquisition Corp. Units
HERAU
|
+$50.2M |
| 4 |
LCIDW
Lucid Group, Inc. Warrant
LCIDW
|
+$42.6M |
| 5 |
CPUH.U
Compute Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
CPUH.U
|
+$42.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.01B |
| 2 |
Amazon
AMZN
|
+$826M |
| 3 |
PayPal
PYPL
|
+$323M |
| 4 |
Meta Platforms (Facebook)
META
|
+$323M |
| 5 |
Salesforce
CRM
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 40% |
| 2 | Communication Services | 26.85% |
| 3 | Technology | 17.68% |
| 4 | Financials | 8.16% |
| 5 | Healthcare | 4.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTAAU
26
DELISTED
FTAC Athena Acquisition Corp. Unit
FTAAU
| $20.1M | 0.13% |
+2,000,000
| New | +$20.7M |
|
27
4D Molecular Therapeutics
FDMT
$496M
| $15.1M | 0.1% |
347,910
-369,824
| -52% | -$16.4M |
|
|
KVSA
28
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $10.1M | 0.07% |
+1,000,000
| New | +$10.3M |
|
|
SVFB
29
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
| $10.1M | 0.07% |
+1,000,000
| New | +$10.4M |
|
30
Adobe
ADBE
$105B
| $9.53M | 0.06% |
20,048
| – | – |
|
|
BTNB
31
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
| $5.12M | 0.03% |
+500,000
| New | +$5.91M |
|
|
PACXW
32
DELISTED
Pioneer Merger Corp. Warrant
PACXW
| $862K | 0.01% |
+916,666
| New | +$1.06M |
|
Similar funds
GH
HT
HAM
FC
FC
VR
MCM
TM
SB Management's Q1 2021 Portfolio in Review
As of Q1 2021, SB Management held 32 positions worth $15.5B, down 12% from $17.7B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
SB Management withdrew a net $2.52B in Q1 2021, reducing 9 holdings. Its largest reduction was Alphabet (Google) Class C, cutting an estimated $1.01B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 42% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SB Management opened a new position in Sana Biotechnology worth $87.9M.
- SB Management's largest Q1 2021 buy was Sana Biotechnology: 2,625,153 shares worth $87.9M.
- SB Management added most to AbCellera Biologics in Q1 2021, an estimated $41.8M increase.
- SB Management's biggest Q1 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.01B.
- SB Management's ten largest holdings make up 96% of its $15.5B portfolio in Q1 2021.
- SB Management opened 20 new positions and closed 0 in Q1 2021.
- SB Management's portfolio value fell 12% quarter-over-quarter to $15.5B.
Based on SB Management's 13F filing for Q1 2021, filed 17 May 2021.